Cargando…
The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies
Glaucomatous optic atrophy is the second most common cause of blindness worldwide, and lowering intraocular pressure (IOP) is the only proven method to slow or stop the progression of the disease. Approximately 40% of patients with elevated IOP will require more than one medication to obtain a modes...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270356/ https://www.ncbi.nlm.nih.gov/pubmed/25540579 http://dx.doi.org/10.2147/OPTH.S76053 |